Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2014
12/10/2014CN103172750B 免疫抑制性多肽与核酸 Immunosuppressive polypeptides and nucleic acid
12/10/2014CN103103090B 蚕蛹虫草酒及其制作方法 Cordyceps wine and its production method
12/10/2014CN103083229B 兽用复方安乃近注射液的制备方法 Veterinary preparation of compound dipyrone injection
12/10/2014CN102988805B 一种治疗过敏性紫癜的中药组合物 A treatment for allergic purpura herbal composition
12/10/2014CN102895263B 去除美洲大蠊提取物中的油脂及其检测方法 American cockroach extract oil and its detection method to remove
12/10/2014CN102821785B 生产过敏原提取物的方法 Production method allergen extract
12/10/2014CN102802641B 用于预防或治疗过敏性疾病的包含含氘的水的组合物及其制备方法 Compositions for the prevention or treatment of allergic diseases comprising water containing deuterium and preparation method
12/10/2014CN102755383B 北五味子提取物及其制备方法、应用 Schisandra extract and its preparation method and application
12/10/2014CN102580082B 一种禽用灭活疫苗及其制备方法 One kind of poultry with inactivated vaccine and its preparation method
12/10/2014CN102552516B 一种治疗过敏性紫癜的中药胶囊及其制备方法 An allergic purpura medicine capsule and preparation method of treatment
12/10/2014CN102321626B 用于抑制蛋白激酶3表达的方法 Method for inhibiting the expression of protein kinase 3
12/10/2014CN101842490B 抗原组合物及其在核酸的靶向递送中的应用 Antigen composition and its application in the targeted delivery of nucleic acids
12/10/2014CN101827936B Cdh3肽以及含有cdh3肽的药剂 Cdh3 peptides and peptide drug containing cdh3
12/10/2014CN101721702B 用于治疗TNF-α相关疾病的人抗体的制剂 For the treatment of TNF-α-related diseases of a human antibody preparation
12/09/2014US8907072 Nucleic acids encoding antibody 137-26 which binds C5 and C5a
12/09/2014US8906884 Method of treating graft-rejection using dextran sulfate
12/09/2014US8906675 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
12/09/2014US8906409 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
12/09/2014US8906375 Methods of using antibodies against human IL-22
12/09/2014US8906374 Combination therapy with CD4 lymphocyte depletion and mTOR inhibitors
12/04/2014US20140357586 Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
12/02/2014US8901104 Use of dextran sulfate
12/02/2014US8900564 Vaccine composition comprising an antigen and a peptide having adjuvant properties
11/2014
11/27/2014US20140350092 Method for inhibiting influenza virus infection
11/25/2014US8895806 Fucosyl transferase gene
11/25/2014US8895722 Splice-region antisense composition and method
11/25/2014US8895721 RNA interference mediating small RNA molecules
11/25/2014US8895718 RNA interference mediating small RNA molecules
11/25/2014US8895006 Ricin ribosome binding protein compositions and methods of use thereof
11/25/2014US8894995 Method of treating a disorder or condition of viral etiology
11/20/2014US20140343091 Beta2-adrenoceptor agonists
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/20/2014US20140342002 Particulate materials
11/20/2014US20140341980 Method to Enhance an Immune Response of Nucleic Acid Vaccination
11/20/2014US20140341948 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/18/2014US8889871 Hepatitis C virus inhibitors
11/18/2014US8889186 Modified release compositions comprising tacrolimus
11/18/2014US8889185 Modified release compositions comprising tacrolimus
11/18/2014US8889181 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/18/2014US8889136 Multiple-variable dose regimen for treating TNFα-related disorders
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/13/2014US20140335607 Methods and compositions relating to restricted expression lentiviral vectors and their applications
11/13/2014US20140335549 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
11/11/2014US8883856 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
11/11/2014US8883825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
11/11/2014US8883803 Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
11/11/2014US8883233 Animal feed composition
11/06/2014US20140330007 2,4-pyrimidinediamine compounds and their uses
11/06/2014US20140328878 Malleable protein matrix and uses thereof
11/04/2014US8877737 Allergy inhibitor
10/2014
10/30/2014US20140325691 Regulation of endogenous gene expression in cells using zinc finger proteins
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/28/2014US8871786 Azaindazole amide compounds as CCR1 receptor antagonists
10/28/2014US8871782 Alkoxy substituted imidazoquinolines
10/28/2014US8871436 Immunostimulatory oligonucleotides and uses thereof
10/28/2014US8871226 Methods and compositions for the treatment and diagnosis of cancer
10/28/2014US8871203 Method of treating a pathological syndrome and a pharmaceutical agent
10/28/2014US8871193 Viral vectors and their use in therapeutic methods
10/23/2014US20140314714 Immunopotentiative composition
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/21/2014US8865643 Recombinant surfactant protein D compositions and methods of use thereof
10/16/2014US20140308311 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/14/2014US8859855 Chimeric PUFA polyketide synthase systems and uses thereof
10/14/2014US8859550 Heterocyclic inhibitors of histamine receptors for the treatment of disease
10/14/2014US8859525 Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
10/14/2014US8858982 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/14/2014US8858917 Methods for limiting spread of pulmonary infections
10/09/2014WO2014165136A1 Constant volume prefilled syringes and kits thereof
10/09/2014WO2014164299A1 Use of levocetirizine and montelukast in the treatment of autoimmune disorders
10/09/2014WO2014163101A1 Fc region variant
10/09/2014WO2014162106A1 Novel chalcone derivatives having an anti-allergic activity
10/09/2014WO2014162036A1 Immunogenic complex for vaccination and method for the production thereof
10/09/2014WO2014161118A1 Pentapeptide, polypeptide, cyclopeptide derivative, and compound and medicament and application thereof
10/09/2014WO2014161090A1 Campylobacter vaccine
10/09/2014US20140303215 Topically applicable pharmaceutical preparation
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/08/2014EP2787081A1 Drug containing carrier into cell for forming immune complex
10/08/2014EP2786996A1 Purinone derivative hydrochloride
10/08/2014EP2786982A1 Amino-propylene-glycol derivatives, preparation method and pharmaceutical composition and use thereof
10/08/2014EP2785828A1 Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
10/08/2014EP2785369A1 Immunogenic plasmodium falciparum antigen compositions and uses thereof
10/08/2014EP2785203A1 Increasing the bioavailability of hydroxycinnamic acids
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853384 RNA interference mediating small RNA molecules
10/07/2014US8853212 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
10/07/2014US8853207 Heterocyclic pyrazole compounds, method for preparing the same and use thereof
10/02/2014WO2014160790A1 Protein production method
10/02/2014WO2014160768A1 Compositions and methods for preparing a subject for organ or non-organ implantation
10/02/2014WO2014160502A1 Uridine nucleoside derivatives, compositions and methods of use
10/02/2014WO2014159923A1 Enhancement of vaccines
10/02/2014WO2014159725A1 Proteins specific for baff and b7rp1 and uses thereof
10/02/2014WO2014159662A1 Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
10/02/2014WO2014159614A1 Adjuvant and antigen particle formulation
10/02/2014WO2014159510A1 Compositions and methods for identifying secretory antibody-bound microbes
10/02/2014WO2014159248A1 Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization
10/02/2014WO2014159052A1 Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
10/02/2014WO2014157687A1 1,2,4-triazine-6-carboxamide derivative with acetamide group
10/02/2014WO2014157603A1 Pharmaceutical composition for oral administration
10/02/2014WO2014157595A1 Novel polypeptides and utilization thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 1172